Letter: Why Assessment of ChILI Severity Accurately Matters?

IF 6.6 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Mar Riveiro-Barciela, Guruprasad P. Aithal
{"title":"Letter: Why Assessment of ChILI Severity Accurately Matters?","authors":"Mar Riveiro-Barciela,&nbsp;Guruprasad P. Aithal","doi":"10.1111/apt.18385","DOIUrl":null,"url":null,"abstract":"<p>In a timely study, Hountondji et al. [<span>1</span>] highlight an important limitation of the Common Terminology Criteria for Adverse Events (CTCAE) classification, which is widely used by oncologists in the management of checkpoint inhibitor-induced liver injury (ChILI). Authors found Drug-induced Liver Injury International Expert Working Group (DILI-IEWG) classification of severity had superior performance characteristics in predicting acute liver injury (compared with CTCAE and Model for End-stage Liver Disease) [<span>2</span>]. One of the reasons for inferior performance of CTCAE is because the latter overestimates severity of ChILI as life-threatening on the basis of alanine transaminase levels of 20-fold upper limit normal alone in isolation of other clinical criteria; this leads to avoidable hospital admissions [<span>3</span>]. In contrast, DILI-IEWG was able to predict 3 months of mortality while v5 of the CTCAE that incorporates total bilirubin was not able to [<span>1</span>].</p><p>Majority of patients with ChILI are started on high-dose corticosteroid therapy based entirely on CTCAE grading despite lack of evidence in its support [<span>4</span>]. A recent study highlights the value of liver biopsy and incorporation of severity of inflammation on liver histology into decision-making regarding corticosteroid therapy in patients with ChILI [<span>5</span>]; following this strategy, two-thirds of patients classified as having severe ChILI were spared of corticosteroid therapy. Early identification of poor outcome is crucial for planning management of ChILI since these patients are not candidates for liver transplantation in case of acute liver failure development [<span>6</span>].</p><p>Although Hountondji et al. [<span>1</span>] focus on the accuracy of methods of grading severity of ChILI, overestimation of severity of this adverse event may lead to unnecessary, prolonged and high dose of corticosteroid therapy in some with consequent complications [<span>4</span>].</p><p><b>Mar Riveiro-Barciela:</b> conceptualization; writing – original draft; investigation. <b>Guruprasad P. Aithal:</b> writing – original draft; supervision; investigation.</p><p>This article is linked to Hountondji et al paper. To view this article, visit https://doi.org/10.1111/apt.18276.</p>","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":"61 1","pages":"240-241"},"PeriodicalIF":6.6000,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.18385","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apt.18385","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In a timely study, Hountondji et al. [1] highlight an important limitation of the Common Terminology Criteria for Adverse Events (CTCAE) classification, which is widely used by oncologists in the management of checkpoint inhibitor-induced liver injury (ChILI). Authors found Drug-induced Liver Injury International Expert Working Group (DILI-IEWG) classification of severity had superior performance characteristics in predicting acute liver injury (compared with CTCAE and Model for End-stage Liver Disease) [2]. One of the reasons for inferior performance of CTCAE is because the latter overestimates severity of ChILI as life-threatening on the basis of alanine transaminase levels of 20-fold upper limit normal alone in isolation of other clinical criteria; this leads to avoidable hospital admissions [3]. In contrast, DILI-IEWG was able to predict 3 months of mortality while v5 of the CTCAE that incorporates total bilirubin was not able to [1].

Majority of patients with ChILI are started on high-dose corticosteroid therapy based entirely on CTCAE grading despite lack of evidence in its support [4]. A recent study highlights the value of liver biopsy and incorporation of severity of inflammation on liver histology into decision-making regarding corticosteroid therapy in patients with ChILI [5]; following this strategy, two-thirds of patients classified as having severe ChILI were spared of corticosteroid therapy. Early identification of poor outcome is crucial for planning management of ChILI since these patients are not candidates for liver transplantation in case of acute liver failure development [6].

Although Hountondji et al. [1] focus on the accuracy of methods of grading severity of ChILI, overestimation of severity of this adverse event may lead to unnecessary, prolonged and high dose of corticosteroid therapy in some with consequent complications [4].

Mar Riveiro-Barciela: conceptualization; writing – original draft; investigation. Guruprasad P. Aithal: writing – original draft; supervision; investigation.

This article is linked to Hountondji et al paper. To view this article, visit https://doi.org/10.1111/apt.18276.

信:为什么辣椒严重程度评估准确重要?
在一项及时的研究中,Hountondji等人强调了不良事件通用术语标准(CTCAE)分类的一个重要局限性,该标准被肿瘤学家广泛用于检查点抑制剂诱导的肝损伤(ChILI)的管理。作者发现药物性肝损伤国际专家工作组(DILI-IEWG)的严重程度分类在预测急性肝损伤方面具有优越的性能特征(与CTCAE和终末期肝病模型相比)[2]。CTCAE表现不佳的原因之一是,后者在排除其他临床标准的情况下,仅以正常上限20倍的丙氨酸转氨酶水平为基础,高估了辣椒的严重程度。这导致了本可避免的住院事故。相比之下,DILI-IEWG能够预测3个月的死亡率,而合并总胆红素的CTCAE的v5无法预测。尽管缺乏证据支持,但大多数ChILI患者完全基于CTCAE分级开始大剂量皮质类固醇治疗。最近的一项研究强调了肝活检的价值,并将肝脏组织学上炎症的严重程度纳入了ChILI bbb患者皮质类固醇治疗的决策中。按照这一策略,三分之二被归类为严重辣椒的患者免于皮质类固醇治疗。早期识别不良预后对于计划管理至关重要,因为这些患者在急性肝功能衰竭发展bbb的情况下不适合肝移植。尽管Hountondji等人[bb1]关注的是ChILI严重程度分级方法的准确性,但过高估计这一不良事件的严重程度可能导致一些患者不必要的、长时间的、高剂量的皮质类固醇治疗,并导致并发症[bb1]。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信